“Doctor Parkinson declared ‘I’m not surprised to see you here, You’ve got smoker’s cough from smoking, brewer’s droop from drinking beer, I don’t know how you came to get the Betty Davis’ knees, But worst of all young man you’ve got Industrial Disease.’ He wrote me a prescription, he said ‘You are depressed, But I’m glad you came to see me to get this off your chest. Come back and see me later – next patient, please – Send in another victim of Industrial Disease.” – Industrial Disease – song by Dire Straits
What would you say if I told you that a bunch of psychiatrists got together and made up hundreds of new mental illnesses based on behaviors that most humans exhibit at one time or another in the normal course of their lives?
And what would be your reaction if I then told you that those conspiratorial and self-serving shrinks approached large pharmaceutical drug manufacturers with an even bigger scheme: sell prescription medications for big profits to all the people who could now be diagnosed medically as “unwell” by the shrinks.
You might say, “This game is rigged.”
And you’d be right.
As far back as 2006, a research paper investigated the mutually beneficial and completely corrupt partnership between American psychiatrists and major drugmakers. First, some background information:
The American Psychiatric Association (APA) is, according to itself, “the leading scientific and professional organization representing psychology in the United States, with more than 121,000 researchers, educators, clinicians, consultants and students as its members.”
Members of the APA claim their mission is to “promote the advancement, communication, and application of psychological science and knowledge to benefit society and improve lives” by using psychology to “make a positive impact on critical societal issues” and to raise “the public’s understanding of, regard for, and use of psychology.”
The truth is that the APA is a shameful society that is far more interested in prescribing drugs to treat the slew of its new medical conditions. Why would they do that if they sincerely want to help people with mental issues?
For more than 5 decades, APA operatives have been quietly dreaming up and cataloging new “mental disorders.” in its definitive Diagnostic and Statistical Manual (DSM) of Mental Disorders. The number of “valid” psychiatric disorders has increased dramatically in recent years, from 130 to 374 (an increase of 244 previously unrecognized mental illnesses).
Each diagnosis listed in the APA’s most up-to-date Fifth Edition of this institutional guide that helps physicians label their patients as mentally deficient has a medical billing code. This means that a treatment facility or doctor’s staff may send invoices to patients to demand payments.
For example, Bipolar Disorder is coded as 296.80 in DMS-IV – the previous edition – which corresponds to a range of allowable fees, depending on the payment method (insurance or self-pay) and perhaps the phase of the moon or the coder’s mood.
In the v.4 DMS (the “psychiatrists’ bible”), Bipolar Disorder further breaks down into sub-categories, all treatable – and billable:
296.56 In Full Remission
296.55 In Partial Remission
296.53 Severe Without Psychotic Features
296.54 Severe With Psychotic Features
Getting back to the 2006 research paper titled “Financial ties between DSM-IV panel members and the pharmaceutical industry,” its authors examined the “potential conflicts of interest in clinical medicine and biomedical sciences, particularly in journal publishing and science advisory panels.”
The researchers revealed financial ties did exist between the pharmaceutical industry and psychiatric panel members responsible for revisions of the Diagnostic and Statistical Manual of Mental Disorders (DSM).
Cosgrove et al. found ” strong financial ties between the [pharmaceutical] industry and those [APA members] who are responsible for developing and modifying the diagnostic criteria for mental illness. The connections are especially strong in those diagnostic areas where drugs are the first line of treatment for mental disorders.”
The study authors recommended full disclosure by DSM panel members “of their financial relationships with for-profit entities that manufacture drugs used in the treatment of mental illness” and called for transparency where possible conflicts of interest occur between the doctors who order drugs for their patients and the drug makers who sell them to the patients – and pay the doctors a kick-back.
ProPublica (“For the People”) has been tracking how many physicians are being paid – bribed – by drug manufacturers to prescribe their brand products rather than those from a competitor or a generic equivalent. In October 2019, the Big Pharma watchdog organization “found over 700 doctors who were paid more than a million dollars by drug and medical device companies.”
Let’s review: the American Psychiatric Association has invented hundreds of new mental illnesses treatable with drugs available only with a doctor’s prescription. The companies that make these drugs pay the physicians large sums of money to hawk their wares to an unsuspecting public.
This game is rigged. Any questions?